Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tauopathies Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tauopathies Treatmentmarket, defines the market attractiveness level of Tauopathies Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tauopathies Treatment industry, describes the types of Tauopathies Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tauopathies Treatment market and the development prospects and opportunities of Tauopathies Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tauopathies Treatment market in Chapter 13.
By Player:
SK Biopharmaceuticals Co, Ltd
Selvita SA
Bristol-Myers Squibb Company
Chronos Therapeutics Limited
By Type:
SEL-141
RDC-5
YM-08
Thiamet-G
Others
By End-User:
Clinic
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tauopathies Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tauopathies Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tauopathies Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tauopathies Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tauopathies Treatment Market Analysis and Outlook to 2022
-
7.1 Global Tauopathies Treatment Consumption (2017-2022)
-
7.2 United States Tauopathies Treatment Consumption (2017-2022)
-
7.3 Europe Tauopathies Treatment Consumption (2017-2022)
-
7.4 China Tauopathies Treatment Consumption (2017-2022)
-
7.5 Japan Tauopathies Treatment Consumption (2017-2022)
-
7.6 India Tauopathies Treatment Consumption (2017-2022)
-
7.7 South Korea Tauopathies Treatment Consumption (2017-2022)
8 Region and Country-wise Tauopathies Treatment Market Analysis and Outlook to 2028
-
8.1 Global Tauopathies Treatment Consumption Forecast (2022-2028)
-
8.2 United States Tauopathies Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Tauopathies Treatment Consumption Forecast (2022-2028)
-
8.4 China Tauopathies Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Tauopathies Treatment Consumption Forecast (2022-2028)
-
8.6 India Tauopathies Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Tauopathies Treatment Consumption Forecast (2022-2028)
9 Global Tauopathies Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Tauopathies Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global SEL-141 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RDC-5 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global YM-08 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Thiamet-G Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Tauopathies Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Tauopathies Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Tauopathies Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global SEL-141 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global RDC-5 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global YM-08 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Thiamet-G Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tauopathies Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Tauopathies Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tauopathies Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tauopathies Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tauopathies Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tauopathies Treatment Market Competitive Analysis
-
14.1 SK Biopharmaceuticals Co, Ltd
-
14.1.1 SK Biopharmaceuticals Co, Ltd Company Details
-
14.1.2 SK Biopharmaceuticals Co, Ltd Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 SK Biopharmaceuticals Co, Ltd Tauopathies Treatment Product and Service
-
14.2 Selvita SA
-
14.2.1 Selvita SA Company Details
-
14.2.2 Selvita SA Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Selvita SA Tauopathies Treatment Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Tauopathies Treatment Product and Service
-
14.4 Chronos Therapeutics Limited
-
14.4.1 Chronos Therapeutics Limited Company Details
-
14.4.2 Chronos Therapeutics Limited Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Chronos Therapeutics Limited Tauopathies Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tauopathies Treatment
-
Figure Tauopathies Treatment Picture
-
Table Global Tauopathies Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tauopathies Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tauopathies Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tauopathies Treatment Consumption by Country (2017-2022)
-
Figure United States Tauopathies Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Tauopathies Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Tauopathies Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Tauopathies Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Tauopathies Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tauopathies Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Tauopathies Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Tauopathies Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tauopathies Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tauopathies Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tauopathies Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tauopathies Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tauopathies Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SEL-141 Consumption and Growth Rate (2017-2022)
-
Figure Global RDC-5 Consumption and Growth Rate (2017-2022)
-
Figure Global YM-08 Consumption and Growth Rate (2017-2022)
-
Figure Global Thiamet-G Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global SEL-141 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RDC-5 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global YM-08 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thiamet-G Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tauopathies Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tauopathies Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table SK Biopharmaceuticals Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table SK Biopharmaceuticals Co, Ltd Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table SK Biopharmaceuticals Co, Ltd Tauopathies Treatment Product and Service
-
Table Selvita SA (Foundation Year, Company Profile and etc.)
-
Table Selvita SA Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Selvita SA Tauopathies Treatment Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Tauopathies Treatment Product and Service
-
Table Chronos Therapeutics Limited (Foundation Year, Company Profile and etc.)
-
Table Chronos Therapeutics Limited Tauopathies Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chronos Therapeutics Limited Tauopathies Treatment Product and Service
-
